Real-world evidence of remdesivir in formerly hospitalized COVID-19 patients: patient-reported and functional outcomes

Abstract Background Post-COVID condition (PCC) is characterized by persisting symptoms after the resolution of acute COVID-19. Remdesivir (RDV), a broad-spectrum antiviral drug, has been widely used in patients hospitalized with COVID-19 requiring oxygen therapy. We aimed to evaluate the effects of...

Full description

Saved in:

Bibliographic Details
Main Authors:	Dorottya Fésü, Enikő Bárczi, Balázs Csoma, Lőrinc Polivka, Márton Boga, Gábor Horváth, János Tamás Varga, Szilvia Sebők, Veronika Müller
Format:	Article
Language:	English
Published:	BMC 2025-01-01
Series:	BMC Infectious Diseases
Subjects:	Post-infectious disorders Post-acute COVID-19 syndrome Symptom burden Antiviral agents Remdesivir Quality of life
Online Access:	https://doi.org/10.1186/s12879-024-10398-w
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Real-world evidence of remdesivir in formerly hospitalized COVID-19 patients: patient-reported and functional outcomes

Similar Items